MIAMI BEACH, Fla. – The second-generation ACURATE neo2 transcatheter heart valve (THV) appears to perform at a similar level to other commercially available contemporary THVs, according to European registry data presented Tuesday at Transcatheter Valve Therapies (TVT) 2021.